Skip to content

Author

W. Ashraf

We have 4 of 54 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Nov 2026

Targeting Seizures and Neurobehavioral Alterations: Efficacy of Brivaracetam-Sertraline Combination in PTZ-Induced Kindling Model.

Epilepsy is a neurological disorder associated with various psychiatric comorbidities, among which anxiety and depressive disorders are most prevalent. These psychiatric comorbidities remain frequently untreated due to concerns about exacerbation of seizures and limited awareness about antidepressant selection. This st...

M. Farooq, S. Javaid, Sadia Younas et al. · 0 citations
Oct 2026

Vitamin B6 augments antidepressant activity of venlafaxine by restoring cortical EEG oscillations, behavior and oxidative biomarkers in chronic unpredictable mild stress (CUMS)-induced model of depression-like behavior.

Combining vitamin B6 with venlafaxine enhances its antidepressant effects, possibly by modulating oxidative stress and neural circuitry, and this combination strategy might be a promising approach to improve therapeutic outcomes in stress-associated depressive disorder.

Fashwa Khan Tareen, S. Javaid, W. Ashraf et al. · 0 citations
Aug 2026

Vitamin B12 and pregabalin combination restored brain waves dynamics and behavior in chronic unpredictable mild stress (CUMS) model of depression.

The use of multimodal network therapy to manipulate neurophysiological resilience in thalamocortical and corticocortical circuitry to modulate depression-like phenotypes and relapse in LLD patients is supported.

Z. Raza, M. Ali, Zohabia Rehman et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.